Trial Profile
A retrospective analysis of the safety and tolerability profile of fingolimod in clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 09 Dec 2015 New trial record